Showing results (1901-1910 of 3,717) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|November 1, 1990
Phase II study of lonidamine in patients with metastatic breast cancer. An Eastern Cooperative Oncology Group studyH I Robins, D S Neuberg, A B Benson, et al.Investigational New Drugs|October 13, 2010
A dose-finding, pharmacokinetic and pharmacodynamic study of a novel schedule of flavopiridol in patients with advanced solid tumorsBhuvaneswari Ramaswamy, Mitch A Phelps, Robert Baiocchi, et al.Investigational New Drugs|October 13, 2010
A phase II open-label trial of bortezomib in patients with multiple myeloma who have undergone an autologous peripheral blood stem cell transplant and failed to achieve a complete responseRobert M Rifkin, Andrew Greenspan, John F Schwerkoske, et al.Investigational New Drugs|February 9, 2011
Management of axitinib (AG-013736)-induced fatigue and thyroid dysfunction, and predictive biomarkers of axitinib exposure: results from phase I studies in Japanese patientsYutaka Fujiwara, Naomi Kiyota, Naoko Chayahara, et al.Investigational New Drugs|February 23, 2011
Inhibition of TGF-β signaling, vasculogenic mimicry and proinflammatory gene expression by isoxanthohumolAnnegret Serwe, Kristina Rudolph, Timm Anke, et al.Investigational New Drugs|February 26, 2011
Targeting angiogenesis from multiple pathways simultaneously: BIBF 1120, an investigational novel triple angiokinase inhibitorEdgardo S Santos, Jorge E Gomez, Luis E RaezInvestigational New Drugs|May 7, 2011
The fate of camptothecin glycoconjugate: report of a clinical hold during a phase II study of BAY 56-3722 (formerly BAY 38-3441), in patients with recurrent or metastatic colorectal cancer resistant/refractory to irinotecanMarije Slingerland, Hans GelderblomInvestigational New Drugs|May 7, 2011
The redox antimalarial dihydroartemisinin targets human metastatic melanoma cells but not primary melanocytes with induction of NOXA-dependent apoptosisChristopher M Cabello, Sarah D Lamore, Warner B Bair, et al.Investigational New Drugs|May 10, 2011
Dasatinib in previously treated metastatic colorectal cancer: a phase II trial of the University of Chicago Phase II ConsortiumManish R Sharma, Kristen Wroblewski, Blase N Polite, et al.Investigational New Drugs|May 10, 2011
Cytotoxic effect of menadione and sodium orthovanadate in combination on human glioma cellsZahid M Delwar, Dimitrios Avramidis, Elna Follin, et al.Pageof 372